AFS.F
Last
- - (-%)Time
-Previous Close
-
Open
-High
-Low
-
Latest News
Alto Neuroscience Starts Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
published on April 21, 2026, 2:34 pm (via MT Newswires)
Related Stocks
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.